Farooq, Saeed
January 2013
Journal of Pakistan Psychiatric Society;Jan-Jun2013, Vol. 10 Issue 1, p1
Academic Journal
The author reflects on the effectiveness of adherence interventions in all medical disciplines, including psychiatry. The author states that estimates and measurement of non adherence is faced by many difficulties and is focused on psychotic disorders. An overview of the problem in measuring and defining non adherence in clinical trials is offered. The author looks into the little attention given to assessment and management of non adherence in routine clinical practice.


Related Articles

  • Drivers and barriers to patient participation in RCTs. Jenkins, V; Farewell, V; Farewell, D; Darmanin, J; Wagstaff, J; Langridge, C; Fallowfield, L // British Journal of Cancer;4/16/2013, Vol. 108 Issue 7, p1402 

    Background:Recruitment of patients into randomised clinical trials (RCTs) is essential for treatment evaluation. Appreciation of the barriers and drivers towards participation is important for trial design, communication and information provision.Method:As part of an intervention to facilitate...

  • Patient adherence data is key to improve trial efficiencies.  // Clinical Trials Administrator;Sep2007, Vol. 5 Issue 9, p99 

    The article discusses the significance of taking patient adherence data to improving clinical trial efficiencies. According to professor Carl C. Peck, incomplete and inaccurate information obtained during a clinical trial can prove dangerous to patients taking the medication later. Trial data...

  • Adherence to antihypertensive medication and association with patient and practice factors. Inkster, M. E.; Donnan, P. T.; MacDonald, T. M.; Sullivan, F. M.; Fahey, T. // Journal of Human Hypertension;Apr2006, Vol. 20 Issue 4, p295 

    The article identifies effective interventions to enhance patient medication adherence to antihypertensive medication. Adherence relates to ability and willingness to abide by a prescribed therapeutic regimen. The finding suggests that adherence to antihypertensive medication is higher than...

  • Lack of Insight in Schizophrenia: Impact on Treatment Adherence. Buckley, Peter F.; Wirshing, Donna A.; Bhushan, Prameet; Pierre, Joseph M.; Resnick, Seth A.; Wirshing, William C. // CNS Drugs;2007, Vol. 21 Issue 2, p129 

    People with schizophrenia commonly lack insight, that is, they are unaware of their illness and the consequences thereof. One of the most important consequences of lack of insight is a failure to recognise the need for treatment, leading to treatment nonadherence. With several scales that now...

  • The effects of motivation feedback in patients with severe mental illness: a cluster randomized controlled trial. Jochems, Eline C.; Van Der Feltz-Cornelis, Christina M.; Van Dam, Arno; Duivenvoorden, Hugo J.; Mulder, Cornelis L. // Neuropsychiatric Disease & Treatment;Dec2015, Vol. 11, p3049 

    Objective: To evaluate the effectiveness of providing clinicians with regular feedback on the patient's motivation for treatment in increasing treatment engagement in patients with severe mental illness. Methods: Design: cluster randomized controlled trial (Dutch Trials Registry NTR2968)....

  • Factors associated with the course and outcome of schizophrenia in India. Results of a two-year multicentre follow-up study. Verghese, A.; John, J.K.; Rajkumar, S.; Richard, J.; Sethi, B.B.; Trivedi, J.K. // British Journal of Psychiatry;Apr89, Vol. 154, p499 

    The paper describes the two-year follow-up results from 323 out of 386 patients fulfilling a modified version of Feighner's criteria for diagnosis of schizophrenia, in Lucknow, Vellore, and Madras. There was remission in 66% of cases. Short duration of illness, consistent compliance with...

  • Involving patients in clinical trial design. Steimes, Philippe // Applied Clinical Trials;Sep2000, Vol. 9 Issue 9, p94 

    Focuses on the importance of patient involvement in the construction of clinical trial design in France. Role of investigators and sponsors in trial designs; Impact of patient participation on the improvement of clinical trial conditions; Protection of subject rights in the ethical approval of...

  • Paper vs. Electronic Diaries. Hufford, Michael R.; Stone, Arthur A.; Shiffman, Saul; Schwartz, Joseph E.; Broderick, Joan E. // Applied Clinical Trials;Aug2002, Vol. 11 Issue 8, p38 

    Evaluates patient compliance with paper and electronic diaries in clinical trials. Falsification of paper diary cards; Subjects' evaluations of paper and electronic diaries; Patterns of compliance.

  • Test Subjects Foil Some Clinical Trials.  // Journal of Dental Hygiene;Winter2001, Vol. 75 Issue 1, p9 

    Reports problem concerning the failure of subjects to adhere to a prescribed medication protocol in clinical trials. Observations of a poor patient compliance in clinical trials and practice; Reasons behind the failure of subjects to take the medications prescribed; Importance of patient...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics